New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement

Breast Cancer Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02926547
• Other study ID #: AOI/2011/PR-01
• Status: Completed
• Start date: March 2014
• Est. completion date: December 2018

Study information

• Verified date: September 2019
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

1. Identify the tissue proteins associated with early breast cancer invasion phases without lymph node involvement .

2. Consider their role in the invasion and the risk of tumor spread .

Recruitment information / eligibility

• Status: Completed
• Enrollment: 108
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Breast cancer

• CCIS

• Invasive tumors

• Breast cancer tissues available in the biobank

Exclusion Criteria:

• non availability of cancer tissue specimen

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	A list of the ten proteins most associated with early breast cancer invasion phases without lymph node involvement .	The primary objective of this study is to Identify the tissue proteins associated with early breast cancer invasion phases without lymph node involvement. The outcome is a list of identified proteins.	Day 0